nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A43—Dexamethasone—multiple sclerosis	0.3	0.372	CbGbCtD
Praziquantel—CYP2D6—Fingolimod—multiple sclerosis	0.0826	0.102	CbGbCtD
Praziquantel—CYP3A4—Fingolimod—multiple sclerosis	0.0525	0.0652	CbGbCtD
Praziquantel—CYP3A7—Dexamethasone—multiple sclerosis	0.0438	0.0543	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0438	0.0543	CbGbCtD
Praziquantel—CYP2C19—Prednisone—multiple sclerosis	0.0424	0.0526	CbGbCtD
Praziquantel—CYP3A4—Methylprednisolone—multiple sclerosis	0.0338	0.042	CbGbCtD
Praziquantel—CYP3A5—Dexamethasone—multiple sclerosis	0.0328	0.0407	CbGbCtD
Praziquantel—CYP2C19—Dexamethasone—multiple sclerosis	0.0265	0.0329	CbGbCtD
Praziquantel—CYP3A4—Triamcinolone—multiple sclerosis	0.0256	0.0318	CbGbCtD
Praziquantel—CYP3A4—Mitoxantrone—multiple sclerosis	0.0247	0.0306	CbGbCtD
Praziquantel—CYP3A4—Betamethasone—multiple sclerosis	0.022	0.0273	CbGbCtD
Praziquantel—CYP3A4—Prednisolone—multiple sclerosis	0.0217	0.0269	CbGbCtD
Praziquantel—CYP3A4—Prednisone—multiple sclerosis	0.0205	0.0254	CbGbCtD
Praziquantel—CYP2D6—Dexamethasone—multiple sclerosis	0.0201	0.025	CbGbCtD
Praziquantel—CYP3A4—Dexamethasone—multiple sclerosis	0.0128	0.0159	CbGbCtD
Praziquantel—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0017	0.0433	CbGpPWpGaD
Praziquantel—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0017	0.0433	CbGpPWpGaD
Praziquantel—CYP3A43—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00168	0.0428	CbGpPWpGaD
Praziquantel—CYP3A43—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00168	0.0428	CbGpPWpGaD
Praziquantel—CYP3A43—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00138	0.0351	CbGpPWpGaD
Praziquantel—CYP3A43—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00138	0.0351	CbGpPWpGaD
Praziquantel—Somnolence—Cladribine—multiple sclerosis	0.000832	0.00537	CcSEcCtD
Praziquantel—Decreased appetite—Cladribine—multiple sclerosis	0.000814	0.00525	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000808	0.00522	CcSEcCtD
Praziquantel—Fatigue—Cladribine—multiple sclerosis	0.000807	0.00521	CcSEcCtD
Praziquantel—Myalgia—Azathioprine—multiple sclerosis	0.000794	0.00513	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000789	0.00509	CcSEcCtD
Praziquantel—Discomfort—Azathioprine—multiple sclerosis	0.000785	0.00506	CcSEcCtD
Praziquantel—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000774	0.005	CcSEcCtD
Praziquantel—Feeling abnormal—Cladribine—multiple sclerosis	0.000772	0.00498	CcSEcCtD
Praziquantel—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000766	0.00494	CcSEcCtD
Praziquantel—Urticaria—Cladribine—multiple sclerosis	0.000744	0.0048	CcSEcCtD
Praziquantel—Body temperature increased—Cladribine—multiple sclerosis	0.00074	0.00478	CcSEcCtD
Praziquantel—Abdominal pain—Cladribine—multiple sclerosis	0.00074	0.00478	CcSEcCtD
Praziquantel—Skin disorder—Azathioprine—multiple sclerosis	0.00074	0.00477	CcSEcCtD
Praziquantel—CYP3A43—Biological oxidations—CYP27B1—multiple sclerosis	0.000733	0.0187	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—CYP24A1—multiple sclerosis	0.000733	0.0187	CbGpPWpGaD
Praziquantel—Bradycardia—Prednisolone—multiple sclerosis	0.000724	0.00467	CcSEcCtD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000723	0.0184	CbGpPWpGaD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000723	0.0184	CbGpPWpGaD
Praziquantel—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.0007	0.00452	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000694	0.00448	CcSEcCtD
Praziquantel—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000691	0.0176	CbGpPWpGaD
Praziquantel—Hypersensitivity—Cladribine—multiple sclerosis	0.00069	0.00445	CcSEcCtD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000685	0.0175	CbGpPWpGaD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000685	0.0175	CbGpPWpGaD
Praziquantel—Malaise—Mitoxantrone—multiple sclerosis	0.00068	0.00439	CcSEcCtD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000676	0.0172	CbGpPWpGaD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000676	0.0172	CbGpPWpGaD
Praziquantel—Asthenia—Cladribine—multiple sclerosis	0.000672	0.00434	CcSEcCtD
Praziquantel—Bradycardia—Triamcinolone—multiple sclerosis	0.000665	0.00429	CcSEcCtD
Praziquantel—Bradycardia—Methylprednisolone—multiple sclerosis	0.000664	0.00429	CcSEcCtD
Praziquantel—Pruritus—Cladribine—multiple sclerosis	0.000662	0.00428	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000657	0.00424	CcSEcCtD
Praziquantel—Convulsion—Mitoxantrone—multiple sclerosis	0.000653	0.00422	CcSEcCtD
Praziquantel—Myalgia—Mitoxantrone—multiple sclerosis	0.000642	0.00414	CcSEcCtD
Praziquantel—Diarrhoea—Cladribine—multiple sclerosis	0.000641	0.00414	CcSEcCtD
Praziquantel—Arrhythmia—Prednisolone—multiple sclerosis	0.000635	0.0041	CcSEcCtD
Praziquantel—Discomfort—Mitoxantrone—multiple sclerosis	0.000634	0.00409	CcSEcCtD
Praziquantel—Feeling abnormal—Azathioprine—multiple sclerosis	0.000627	0.00405	CcSEcCtD
Praziquantel—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000623	0.00402	CcSEcCtD
Praziquantel—Dizziness—Cladribine—multiple sclerosis	0.000619	0.004	CcSEcCtD
Praziquantel—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000605	0.00391	CcSEcCtD
Praziquantel—Bradycardia—Betamethasone—multiple sclerosis	0.000604	0.0039	CcSEcCtD
Praziquantel—Bradycardia—Dexamethasone—multiple sclerosis	0.000604	0.0039	CcSEcCtD
Praziquantel—Abdominal pain—Azathioprine—multiple sclerosis	0.000602	0.00388	CcSEcCtD
Praziquantel—Body temperature increased—Azathioprine—multiple sclerosis	0.000602	0.00388	CcSEcCtD
Praziquantel—Skin disorder—Mitoxantrone—multiple sclerosis	0.000598	0.00386	CcSEcCtD
Praziquantel—Vomiting—Cladribine—multiple sclerosis	0.000595	0.00384	CcSEcCtD
Praziquantel—Rash—Cladribine—multiple sclerosis	0.00059	0.00381	CcSEcCtD
Praziquantel—Dermatitis—Cladribine—multiple sclerosis	0.00059	0.00381	CcSEcCtD
Praziquantel—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000589	0.0038	CcSEcCtD
Praziquantel—Anorexia—Mitoxantrone—multiple sclerosis	0.000587	0.00379	CcSEcCtD
Praziquantel—Headache—Cladribine—multiple sclerosis	0.000587	0.00379	CcSEcCtD
Praziquantel—Arrhythmia—Triamcinolone—multiple sclerosis	0.000584	0.00377	CcSEcCtD
Praziquantel—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000583	0.00376	CcSEcCtD
Praziquantel—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000574	0.00371	CcSEcCtD
Praziquantel—Hypersensitivity—Azathioprine—multiple sclerosis	0.000561	0.00362	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000561	0.00362	CcSEcCtD
Praziquantel—Malaise—Prednisolone—multiple sclerosis	0.000558	0.0036	CcSEcCtD
Praziquantel—Nausea—Cladribine—multiple sclerosis	0.000556	0.00359	CcSEcCtD
Praziquantel—Vertigo—Prednisolone—multiple sclerosis	0.000556	0.00359	CcSEcCtD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000555	0.0142	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000555	0.0142	CbGpPWpGaD
Praziquantel—Somnolence—Mitoxantrone—multiple sclerosis	0.000547	0.00353	CcSEcCtD
Praziquantel—Convulsion—Prednisolone—multiple sclerosis	0.000536	0.00346	CcSEcCtD
Praziquantel—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000535	0.00345	CcSEcCtD
Praziquantel—Eosinophilia—Methotrexate—multiple sclerosis	0.000534	0.00345	CcSEcCtD
Praziquantel—Fatigue—Mitoxantrone—multiple sclerosis	0.000531	0.00343	CcSEcCtD
Praziquantel—Arrhythmia—Betamethasone—multiple sclerosis	0.00053	0.00342	CcSEcCtD
Praziquantel—Arrhythmia—Dexamethasone—multiple sclerosis	0.00053	0.00342	CcSEcCtD
Praziquantel—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000528	0.00341	CcSEcCtD
Praziquantel—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000527	0.0034	CcSEcCtD
Praziquantel—Bradycardia—Prednisone—multiple sclerosis	0.000526	0.00339	CcSEcCtD
Praziquantel—Diarrhoea—Azathioprine—multiple sclerosis	0.000521	0.00336	CcSEcCtD
Praziquantel—Discomfort—Prednisolone—multiple sclerosis	0.00052	0.00336	CcSEcCtD
Praziquantel—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000517	0.00334	CcSEcCtD
Praziquantel—Malaise—Triamcinolone—multiple sclerosis	0.000513	0.00331	CcSEcCtD
Praziquantel—Malaise—Methylprednisolone—multiple sclerosis	0.000512	0.0033	CcSEcCtD
Praziquantel—Vertigo—Triamcinolone—multiple sclerosis	0.000511	0.0033	CcSEcCtD
Praziquantel—Vertigo—Methylprednisolone—multiple sclerosis	0.00051	0.00329	CcSEcCtD
Praziquantel—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000507	0.00327	CcSEcCtD
Praziquantel—Dizziness—Azathioprine—multiple sclerosis	0.000503	0.00325	CcSEcCtD
Praziquantel—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000503	0.00325	CcSEcCtD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000495	0.0126	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000495	0.0126	CbGpPWpGaD
Praziquantel—Convulsion—Triamcinolone—multiple sclerosis	0.000493	0.00318	CcSEcCtD
Praziquantel—Convulsion—Methylprednisolone—multiple sclerosis	0.000492	0.00317	CcSEcCtD
Praziquantel—Urticaria—Mitoxantrone—multiple sclerosis	0.000489	0.00316	CcSEcCtD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000489	0.0125	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000489	0.0125	CbGpPWpGaD
Praziquantel—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000487	0.00314	CcSEcCtD
Praziquantel—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000487	0.00314	CcSEcCtD
Praziquantel—Myalgia—Triamcinolone—multiple sclerosis	0.000484	0.00313	CcSEcCtD
Praziquantel—Vomiting—Azathioprine—multiple sclerosis	0.000484	0.00312	CcSEcCtD
Praziquantel—Myalgia—Methylprednisolone—multiple sclerosis	0.000483	0.00312	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—multiple sclerosis	0.000481	0.0031	CcSEcCtD
Praziquantel—Rash—Azathioprine—multiple sclerosis	0.00048	0.0031	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00048	0.0031	CcSEcCtD
Praziquantel—Dermatitis—Azathioprine—multiple sclerosis	0.00048	0.0031	CcSEcCtD
Praziquantel—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000479	0.00309	CcSEcCtD
Praziquantel—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000479	0.00309	CcSEcCtD
Praziquantel—Discomfort—Triamcinolone—multiple sclerosis	0.000479	0.00309	CcSEcCtD
Praziquantel—Discomfort—Methylprednisolone—multiple sclerosis	0.000478	0.00308	CcSEcCtD
Praziquantel—Headache—Azathioprine—multiple sclerosis	0.000477	0.00308	CcSEcCtD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00047	0.012	CbGpPWpGaD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00047	0.012	CbGpPWpGaD
Praziquantel—Immune system disorder—Prednisone—multiple sclerosis	0.000467	0.00301	CcSEcCtD
Praziquantel—Malaise—Dexamethasone—multiple sclerosis	0.000466	0.00301	CcSEcCtD
Praziquantel—Malaise—Betamethasone—multiple sclerosis	0.000466	0.00301	CcSEcCtD
Praziquantel—Vertigo—Dexamethasone—multiple sclerosis	0.000464	0.00299	CcSEcCtD
Praziquantel—Vertigo—Betamethasone—multiple sclerosis	0.000464	0.00299	CcSEcCtD
Praziquantel—Arrhythmia—Prednisone—multiple sclerosis	0.000461	0.00298	CcSEcCtD
Praziquantel—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000454	0.00293	CcSEcCtD
Praziquantel—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000453	0.00293	CcSEcCtD
Praziquantel—Nausea—Azathioprine—multiple sclerosis	0.000452	0.00292	CcSEcCtD
Praziquantel—Skin disorder—Methylprednisolone—multiple sclerosis	0.00045	0.0029	CcSEcCtD
Praziquantel—Convulsion—Dexamethasone—multiple sclerosis	0.000447	0.00289	CcSEcCtD
Praziquantel—Convulsion—Betamethasone—multiple sclerosis	0.000447	0.00289	CcSEcCtD
Praziquantel—Asthenia—Mitoxantrone—multiple sclerosis	0.000442	0.00285	CcSEcCtD
Praziquantel—Myalgia—Dexamethasone—multiple sclerosis	0.00044	0.00284	CcSEcCtD
Praziquantel—Myalgia—Betamethasone—multiple sclerosis	0.00044	0.00284	CcSEcCtD
Praziquantel—Discomfort—Betamethasone—multiple sclerosis	0.000434	0.0028	CcSEcCtD
Praziquantel—Discomfort—Dexamethasone—multiple sclerosis	0.000434	0.0028	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000423	0.00273	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000422	0.00272	CcSEcCtD
Praziquantel—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000421	0.00272	CcSEcCtD
Praziquantel—Ill-defined disorder—Prednisone—multiple sclerosis	0.000417	0.00269	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisolone—multiple sclerosis	0.000416	0.00269	CcSEcCtD
Praziquantel—Nervous system disorder—Betamethasone—multiple sclerosis	0.000413	0.00267	CcSEcCtD
Praziquantel—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000413	0.00267	CcSEcCtD
Praziquantel—Malaise—Prednisone—multiple sclerosis	0.000405	0.00262	CcSEcCtD
Praziquantel—Vertigo—Prednisone—multiple sclerosis	0.000404	0.00261	CcSEcCtD
Praziquantel—Anorexia—Betamethasone—multiple sclerosis	0.000402	0.00259	CcSEcCtD
Praziquantel—Anorexia—Dexamethasone—multiple sclerosis	0.000402	0.00259	CcSEcCtD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000402	0.0102	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000402	0.0102	CbGpPWpGaD
Praziquantel—Urticaria—Prednisolone—multiple sclerosis	0.000401	0.00259	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—multiple sclerosis	0.000401	0.00259	CcSEcCtD
Praziquantel—Fatigue—Triamcinolone—multiple sclerosis	0.0004	0.00258	CcSEcCtD
Praziquantel—Fatigue—Methylprednisolone—multiple sclerosis	0.000399	0.00258	CcSEcCtD
Praziquantel—Vomiting—Mitoxantrone—multiple sclerosis	0.000391	0.00253	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—multiple sclerosis	0.00039	0.00252	CcSEcCtD
Praziquantel—Convulsion—Prednisone—multiple sclerosis	0.00039	0.00251	CcSEcCtD
Praziquantel—Rash—Mitoxantrone—multiple sclerosis	0.000388	0.0025	CcSEcCtD
Praziquantel—Dermatitis—Mitoxantrone—multiple sclerosis	0.000388	0.0025	CcSEcCtD
Praziquantel—Headache—Mitoxantrone—multiple sclerosis	0.000386	0.00249	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000384	0.00248	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000384	0.00248	CcSEcCtD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000383	0.00976	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000383	0.00976	CbGpPWpGaD
Praziquantel—Myalgia—Prednisone—multiple sclerosis	0.000383	0.00247	CcSEcCtD
Praziquantel—CYP3A43—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000383	0.00975	CbGpPWpGaD
Praziquantel—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000383	0.00247	CcSEcCtD
Praziquantel—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000382	0.00246	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00038	0.00245	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000379	0.00245	CcSEcCtD
Praziquantel—Discomfort—Prednisone—multiple sclerosis	0.000378	0.00244	CcSEcCtD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000378	0.00963	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000378	0.00963	CbGpPWpGaD
Praziquantel—Hypersensitivity—Prednisolone—multiple sclerosis	0.000372	0.0024	CcSEcCtD
Praziquantel—Urticaria—Triamcinolone—multiple sclerosis	0.000369	0.00238	CcSEcCtD
Praziquantel—Urticaria—Methylprednisolone—multiple sclerosis	0.000368	0.00238	CcSEcCtD
Praziquantel—Body temperature increased—Triamcinolone—multiple sclerosis	0.000367	0.00237	CcSEcCtD
Praziquantel—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000366	0.00236	CcSEcCtD
Praziquantel—Decreased appetite—Dexamethasone—multiple sclerosis	0.000366	0.00236	CcSEcCtD
Praziquantel—Decreased appetite—Betamethasone—multiple sclerosis	0.000366	0.00236	CcSEcCtD
Praziquantel—Nausea—Mitoxantrone—multiple sclerosis	0.000366	0.00236	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000364	0.00235	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000364	0.00235	CcSEcCtD
Praziquantel—Fatigue—Dexamethasone—multiple sclerosis	0.000363	0.00234	CcSEcCtD
Praziquantel—Fatigue—Betamethasone—multiple sclerosis	0.000363	0.00234	CcSEcCtD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000363	0.00924	CbGpPWpGaD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000363	0.00924	CbGpPWpGaD
Praziquantel—Nervous system disorder—Prednisone—multiple sclerosis	0.00036	0.00232	CcSEcCtD
Praziquantel—Skin disorder—Prednisone—multiple sclerosis	0.000356	0.0023	CcSEcCtD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000352	0.00897	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000352	0.00897	CbGpPWpGaD
Praziquantel—Anorexia—Prednisone—multiple sclerosis	0.00035	0.00226	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000349	0.00225	CcSEcCtD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000348	0.00885	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000348	0.00885	CbGpPWpGaD
Praziquantel—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000347	0.00224	CcSEcCtD
Praziquantel—Feeling abnormal—Betamethasone—multiple sclerosis	0.000347	0.00224	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000345	0.00222	CcSEcCtD
Praziquantel—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000345	0.00222	CcSEcCtD
Praziquantel—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000342	0.00221	CcSEcCtD
Praziquantel—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000341	0.0022	CcSEcCtD
Praziquantel—Malaise—Methotrexate—multiple sclerosis	0.000339	0.00219	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—multiple sclerosis	0.000338	0.00218	CcSEcCtD
Praziquantel—Urticaria—Betamethasone—multiple sclerosis	0.000335	0.00216	CcSEcCtD
Praziquantel—Urticaria—Dexamethasone—multiple sclerosis	0.000335	0.00216	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000334	0.00216	CcSEcCtD
Praziquantel—Dizziness—Prednisolone—multiple sclerosis	0.000334	0.00216	CcSEcCtD
Praziquantel—Asthenia—Triamcinolone—multiple sclerosis	0.000333	0.00215	CcSEcCtD
Praziquantel—Abdominal pain—Betamethasone—multiple sclerosis	0.000333	0.00215	CcSEcCtD
Praziquantel—Abdominal pain—Dexamethasone—multiple sclerosis	0.000333	0.00215	CcSEcCtD
Praziquantel—Body temperature increased—Dexamethasone—multiple sclerosis	0.000333	0.00215	CcSEcCtD
Praziquantel—Body temperature increased—Betamethasone—multiple sclerosis	0.000333	0.00215	CcSEcCtD
Praziquantel—Asthenia—Methylprednisolone—multiple sclerosis	0.000332	0.00215	CcSEcCtD
Praziquantel—Pruritus—Triamcinolone—multiple sclerosis	0.000329	0.00212	CcSEcCtD
Praziquantel—Pruritus—Methylprednisolone—multiple sclerosis	0.000328	0.00212	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—multiple sclerosis	0.000326	0.0021	CcSEcCtD
Praziquantel—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000321	0.00818	CbGpPWpGaD
Praziquantel—Myalgia—Methotrexate—multiple sclerosis	0.00032	0.00206	CcSEcCtD
Praziquantel—Decreased appetite—Prednisone—multiple sclerosis	0.000319	0.00206	CcSEcCtD
Praziquantel—Rash—Prednisolone—multiple sclerosis	0.000318	0.00206	CcSEcCtD
Praziquantel—Dermatitis—Prednisolone—multiple sclerosis	0.000318	0.00205	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000318	0.00205	CcSEcCtD
Praziquantel—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000317	0.00205	CcSEcCtD
Praziquantel—Fatigue—Prednisone—multiple sclerosis	0.000316	0.00204	CcSEcCtD
Praziquantel—Headache—Prednisolone—multiple sclerosis	0.000316	0.00204	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—multiple sclerosis	0.000316	0.00204	CcSEcCtD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00031	0.00791	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00031	0.00791	CbGpPWpGaD
Praziquantel—CYP3A43—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00031	0.0079	CbGpPWpGaD
Praziquantel—Dizziness—Triamcinolone—multiple sclerosis	0.000307	0.00198	CcSEcCtD
Praziquantel—Dizziness—Methylprednisolone—multiple sclerosis	0.000306	0.00198	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisone—multiple sclerosis	0.000302	0.00195	CcSEcCtD
Praziquantel—Asthenia—Betamethasone—multiple sclerosis	0.000302	0.00195	CcSEcCtD
Praziquantel—Asthenia—Dexamethasone—multiple sclerosis	0.000302	0.00195	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—multiple sclerosis	0.000301	0.00194	CcSEcCtD
Praziquantel—Gastrointestinal pain—Prednisone—multiple sclerosis	0.0003	0.00194	CcSEcCtD
Praziquantel—Nausea—Prednisolone—multiple sclerosis	0.0003	0.00194	CcSEcCtD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000298	0.0076	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000298	0.0076	CbGpPWpGaD
Praziquantel—Pruritus—Betamethasone—multiple sclerosis	0.000298	0.00192	CcSEcCtD
Praziquantel—Pruritus—Dexamethasone—multiple sclerosis	0.000298	0.00192	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—multiple sclerosis	0.000298	0.00192	CcSEcCtD
Praziquantel—Vomiting—Triamcinolone—multiple sclerosis	0.000295	0.00191	CcSEcCtD
Praziquantel—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000295	0.00752	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000295	0.00752	CbGpPWpGaD
Praziquantel—Vomiting—Methylprednisolone—multiple sclerosis	0.000295	0.0019	CcSEcCtD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000294	0.0075	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000294	0.0075	CbGpPWpGaD
Praziquantel—Rash—Triamcinolone—multiple sclerosis	0.000293	0.00189	CcSEcCtD
Praziquantel—Dermatitis—Triamcinolone—multiple sclerosis	0.000293	0.00189	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—multiple sclerosis	0.000292	0.00189	CcSEcCtD
Praziquantel—Rash—Methylprednisolone—multiple sclerosis	0.000292	0.00189	CcSEcCtD
Praziquantel—Dermatitis—Methylprednisolone—multiple sclerosis	0.000292	0.00188	CcSEcCtD
Praziquantel—Urticaria—Prednisone—multiple sclerosis	0.000291	0.00188	CcSEcCtD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000291	0.00741	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000291	0.00741	CbGpPWpGaD
Praziquantel—Headache—Triamcinolone—multiple sclerosis	0.000291	0.00188	CcSEcCtD
Praziquantel—Headache—Methylprednisolone—multiple sclerosis	0.00029	0.00187	CcSEcCtD
Praziquantel—Abdominal pain—Prednisone—multiple sclerosis	0.00029	0.00187	CcSEcCtD
Praziquantel—Body temperature increased—Prednisone—multiple sclerosis	0.00029	0.00187	CcSEcCtD
Praziquantel—Diarrhoea—Dexamethasone—multiple sclerosis	0.000288	0.00186	CcSEcCtD
Praziquantel—Diarrhoea—Betamethasone—multiple sclerosis	0.000288	0.00186	CcSEcCtD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000286	0.00727	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000286	0.00727	CbGpPWpGaD
Praziquantel—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000279	0.0018	CcSEcCtD
Praziquantel—Dizziness—Dexamethasone—multiple sclerosis	0.000279	0.0018	CcSEcCtD
Praziquantel—Dizziness—Betamethasone—multiple sclerosis	0.000279	0.0018	CcSEcCtD
Praziquantel—Nausea—Triamcinolone—multiple sclerosis	0.000276	0.00178	CcSEcCtD
Praziquantel—Nausea—Methylprednisolone—multiple sclerosis	0.000275	0.00178	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—multiple sclerosis	0.000273	0.00176	CcSEcCtD
Praziquantel—Hypersensitivity—Prednisone—multiple sclerosis	0.00027	0.00174	CcSEcCtD
Praziquantel—Vomiting—Dexamethasone—multiple sclerosis	0.000268	0.00173	CcSEcCtD
Praziquantel—Vomiting—Betamethasone—multiple sclerosis	0.000268	0.00173	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—multiple sclerosis	0.000267	0.00172	CcSEcCtD
Praziquantel—Rash—Betamethasone—multiple sclerosis	0.000266	0.00171	CcSEcCtD
Praziquantel—Rash—Dexamethasone—multiple sclerosis	0.000266	0.00171	CcSEcCtD
Praziquantel—Dermatitis—Dexamethasone—multiple sclerosis	0.000265	0.00171	CcSEcCtD
Praziquantel—Dermatitis—Betamethasone—multiple sclerosis	0.000265	0.00171	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000265	0.00171	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—multiple sclerosis	0.000264	0.00171	CcSEcCtD
Praziquantel—Headache—Betamethasone—multiple sclerosis	0.000264	0.0017	CcSEcCtD
Praziquantel—Headache—Dexamethasone—multiple sclerosis	0.000264	0.0017	CcSEcCtD
Praziquantel—Asthenia—Prednisone—multiple sclerosis	0.000263	0.0017	CcSEcCtD
Praziquantel—Pruritus—Prednisone—multiple sclerosis	0.00026	0.00168	CcSEcCtD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000256	0.00652	CbGpPWpGaD
Praziquantel—Feeling abnormal—Methotrexate—multiple sclerosis	0.000253	0.00163	CcSEcCtD
Praziquantel—Diarrhoea—Prednisone—multiple sclerosis	0.000251	0.00162	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000251	0.00162	CcSEcCtD
Praziquantel—Nausea—Betamethasone—multiple sclerosis	0.00025	0.00162	CcSEcCtD
Praziquantel—Nausea—Dexamethasone—multiple sclerosis	0.00025	0.00162	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—multiple sclerosis	0.000244	0.00157	CcSEcCtD
Praziquantel—Dizziness—Prednisone—multiple sclerosis	0.000243	0.00157	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—multiple sclerosis	0.000242	0.00156	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—multiple sclerosis	0.000242	0.00156	CcSEcCtD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000242	0.00616	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000242	0.00616	CbGpPWpGaD
Praziquantel—Vomiting—Prednisone—multiple sclerosis	0.000233	0.00151	CcSEcCtD
Praziquantel—Rash—Prednisone—multiple sclerosis	0.000231	0.00149	CcSEcCtD
Praziquantel—Dermatitis—Prednisone—multiple sclerosis	0.000231	0.00149	CcSEcCtD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00023	0.00587	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00023	0.00587	CbGpPWpGaD
Praziquantel—Headache—Prednisone—multiple sclerosis	0.00023	0.00148	CcSEcCtD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000227	0.00579	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000227	0.00579	CbGpPWpGaD
Praziquantel—Hypersensitivity—Methotrexate—multiple sclerosis	0.000226	0.00146	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—multiple sclerosis	0.00022	0.00142	CcSEcCtD
Praziquantel—Nausea—Prednisone—multiple sclerosis	0.000218	0.00141	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—multiple sclerosis	0.000217	0.0014	CcSEcCtD
Praziquantel—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000213	0.00543	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000213	0.00543	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00021	0.00536	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00021	0.00536	CbGpPWpGaD
Praziquantel—Diarrhoea—Methotrexate—multiple sclerosis	0.00021	0.00135	CcSEcCtD
Praziquantel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000207	0.00526	CbGpPWpGaD
Praziquantel—Dizziness—Methotrexate—multiple sclerosis	0.000203	0.00131	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—multiple sclerosis	0.000195	0.00126	CcSEcCtD
Praziquantel—Rash—Methotrexate—multiple sclerosis	0.000193	0.00125	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—multiple sclerosis	0.000193	0.00125	CcSEcCtD
Praziquantel—Headache—Methotrexate—multiple sclerosis	0.000192	0.00124	CcSEcCtD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000187	0.00476	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000187	0.00476	CbGpPWpGaD
Praziquantel—Nausea—Methotrexate—multiple sclerosis	0.000182	0.00118	CcSEcCtD
Praziquantel—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000179	0.00457	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—SRM—multiple sclerosis	0.000178	0.00453	CbGpPWpGaD
Praziquantel—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000165	0.0042	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000165	0.0042	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000165	0.0042	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—POMC—multiple sclerosis	0.000165	0.0042	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000163	0.00414	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000163	0.00414	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000161	0.00409	CbGpPWpGaD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000154	0.00393	CbGpPWpGaD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000154	0.00392	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000152	0.00386	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000152	0.00386	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00015	0.00381	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00015	0.00381	CbGpPWpGaD
Praziquantel—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000142	0.00362	CbGpPWpGaD
Praziquantel—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00014	0.00356	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000128	0.00327	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000128	0.00327	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000127	0.00323	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000127	0.00323	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP27B1—multiple sclerosis	0.000125	0.00319	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP24A1—multiple sclerosis	0.000125	0.00319	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000125	0.00318	CbGpPWpGaD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000119	0.00302	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GPC5—multiple sclerosis	0.000115	0.00292	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000111	0.00284	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.92e-05	0.00253	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.92e-05	0.00253	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.78e-05	0.00249	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.78e-05	0.00249	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—RRM1—multiple sclerosis	9.49e-05	0.00242	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.03e-05	0.0023	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.61e-05	0.00219	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.92e-05	0.00202	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SRM—multiple sclerosis	7.16e-05	0.00182	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.98e-05	0.00178	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.91e-05	0.00176	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.71e-05	0.00171	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—POMC—multiple sclerosis	6.64e-05	0.00169	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.42e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.33e-05	0.00161	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.33e-05	0.00161	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.16e-05	0.00157	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.14e-05	0.00156	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—BCHE—multiple sclerosis	5.45e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.44e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.18e-05	0.00132	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SRM—multiple sclerosis	5.18e-05	0.00132	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	5.05e-05	0.00129	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	5.05e-05	0.00129	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.93e-05	0.00126	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.93e-05	0.00126	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.8e-05	0.00122	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.8e-05	0.00122	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.79e-05	0.00122	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.69e-05	0.0012	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.62e-05	0.00118	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.47e-05	0.00114	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.47e-05	0.00114	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.2e-05	0.00107	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SRM—multiple sclerosis	4e-05	0.00102	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.82e-05	0.000974	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.71e-05	0.000945	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000938	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.65e-05	0.000929	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.65e-05	0.000929	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.000869	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.34e-05	0.00085	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—APOE—multiple sclerosis	3.28e-05	0.000836	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SRM—multiple sclerosis	3.12e-05	0.000795	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.89e-05	0.000736	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.82e-05	0.000718	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.82e-05	0.000718	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—POMC—multiple sclerosis	2.82e-05	0.000718	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.76e-05	0.000704	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.76e-05	0.000702	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.000661	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.000661	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.58e-05	0.000657	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ALB—multiple sclerosis	2.57e-05	0.000655	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SRM—multiple sclerosis	2.41e-05	0.000613	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000604	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.23e-05	0.000568	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.2e-05	0.00056	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.2e-05	0.00056	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.2e-05	0.00056	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.15e-05	0.000547	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.14e-05	0.000544	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.01e-05	0.000512	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000501	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.7e-05	0.000432	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.7e-05	0.000432	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.67e-05	0.000424	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.66e-05	0.000422	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.000404	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.000395	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.42e-05	0.000363	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—APOE—multiple sclerosis	1.32e-05	0.000337	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.3e-05	0.000331	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.29e-05	0.000329	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000327	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.000313	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—POMC—multiple sclerosis	1.14e-05	0.000289	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000288	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.11e-05	0.000283	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000264	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.01e-05	0.000258	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.56e-06	0.000244	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—APOE—multiple sclerosis	9.55e-06	0.000243	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—POMC—multiple sclerosis	8.21e-06	0.000209	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALB—multiple sclerosis	7.48e-06	0.000191	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—APOE—multiple sclerosis	7.38e-06	0.000188	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.38e-06	0.000188	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—APOE—multiple sclerosis	6.79e-06	0.000173	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—POMC—multiple sclerosis	6.34e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—POMC—multiple sclerosis	5.83e-06	0.000149	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALB—multiple sclerosis	5.78e-06	0.000147	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—APOE—multiple sclerosis	5.75e-06	0.000147	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALB—multiple sclerosis	5.32e-06	0.000136	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—POMC—multiple sclerosis	4.94e-06	0.000126	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALB—multiple sclerosis	4.51e-06	0.000115	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—APOE—multiple sclerosis	4.44e-06	0.000113	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—POMC—multiple sclerosis	3.81e-06	9.72e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALB—multiple sclerosis	3.48e-06	8.86e-05	CbGpPWpGaD
